- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Alkem Labs Receives Rs 9.72 Lakh GST Demand for FY 2021-22

The GST order mainly alleges the levy of tax under the Reverse Charge Mechanism and excess availment of Input Tax Credit (ITC).
Calcutta: Alkem Laboratories Limited has received an order under the Goods and Services Tax (GST) Act, 2017, from the Deputy Commissioner, Large Taxpayer Unit, Corporate Division, West Bengal, raising a tax demand of Rs 9,71,866 for the financial year 2021-22.
The order, pertaining to the company’s West Bengal GSTIN, was received on December 29, 2025.
In a regulatory filing, the company stated that the statutory authority has demanded GST of Rs 5,20,601, along with interest amounting to Rs 3,89,167 and a penalty of Rs 62,098. The demand has been raised under the applicable provisions of the IGST Act, 2017, CGST Act, 2017, and SGST Act, 2017.
According to the details disclosed, the GST order mainly alleges the levy of tax under the Reverse Charge Mechanism and excess availment of Input Tax Credit (ITC). Alkem Laboratories has clarified that it does not agree with the allegations and the demand raised in the order.
The company further stated that it is in the process of taking appropriate legal action, including but not limited to filing an appeal against the order before the competent authority. Alkem Laboratories emphasized that the GST demand will not have any material impact on its financial position, operations, or other business activities.
Alkem Laboratories also informed that the details of the order have been uploaded on its official website for stakeholder information.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

